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Abstract	
 Gasdermin	D	(GSDMD)	is	a	protein	encoded	by	the	GSDMD	gene	and	is	found	in	the	epithelial	tissue	and	immune	cells	of	humans.	GSDMD	is	known	to	be	cleaved	into	two	segments,	the	pore	forming	domain	on	the	N-terminal	and	the	repressor	domain	on	the	C-terminal,	by	inflammatory	caspases	1,	4,	5,	and	11.	Various	bacterial	strains	were	used	to	infect	mouse	macrophages	with	and	without	the	GSDMD	gene.	The	quantified	difference	in	cell	death	between	the	two	groups	emphasizes	the	role	of	the	GSDMD	protein	in	the	pyroptosis	pathway.			 	
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Chapter	1	-	Introduction	and	Background	
Gasdermin	Superfamily	Gasdermins	are	a	family	of	genes	found	in	the	epithelial	tissue	and	mucous	membranes	of	humans.	This	set	of	genes	is	highly	specified	to	only	a	few	types	of	epithelial	cells.	The	human	Gasdermin	superfamily	consists	of	GSDMA,	GSDMB,	GSDMC,	GSDMD	and	related	protein	DFNA5	and	DFNB59.	The	mouse	Gasdermin	superfamily	consists	of	Gsdma1-3,	Gsdmc1-4,	and	Gsdmd	as	well	as	the	related	protein	Dfna5h	and	Dfnb59	(Tamura	et	al.,	2007).	The	figure	in	Appendix	A	contains	the	exact	chromosomal	locations	of	each	of	the	genes	for	both	mice	and	human	models.	These	genes	are	found	in	a	variety	of	cell	types	in	the	body	of	both	mice	and	humans.	Table	1	below	shows	the	locations	of	expression	of	each	gene	in	the	Gasdermin	superfamily	(Saeki	&	Sasaki,	2012).			
Table	1:	Gasdermin	Superfamily	Expression	Sites	(Saeki	&	Sasaki,	2012)	
	All	of	the	members	of	the	Gasdermin	Superfamily	are	expressed	in	the	gastrointestinal	tract	of	humans	as	well	as	other	epithelial	cells.	Gasdermin	A	and	Gasdermin	C	are	expressed	in	the	mature	differentiated	cell	layer.	Gasdermin	B	is	expressed	near	stem	cells,	indicating	that	it	may	be	tied	to	highly	proliferating	cells.	Gasdermin	D	is	mainly	expressed	in	differentiating	cells	(Saeki	&	Sasaki,	2012).	Although	DFNA5	and	DFNB59	have	a	conserved	amino	acid	domain	consistent	with	the	other	members	of	the	Gasdermin	family,	the	structures	are	not	similar	enough	to	have	these	genes	included	in	the	immediate	family,	thus	leading	them	to	be	categorized	in	the	Gasdermin	superfamily	instead(Tamura	et	al.,	2007).	Gasdermins	are	known	to	be	involved	in	multiple	types	of	cancers,	but	they	are	hypothesized	to	
act	as	tumor	suppressors	due	to	their	heavy	involvement	in	cell	differentiation	and	regulation	of	pyroptosis	(Aglietti	&	Dueber,	2017).	A	dominant	mutation	of	DFNA5	has	been	found	to	be	the	cause	of	nonsyndromic	hearing	loss	in	humans	(Ding	et	al.,	2016).	
Gasdermin	D	Structure	GSDMD	was	the	gene	of	focus	for	the	experiments	conduced	in	this	project.	The	protein	that	is	encoded	by	Gasdermin	D	in	humans	is	called	hGSDMD,	and	the	protein	is	called	mGSDMD	in	mice.	It	is	comprised	of	two	distinct	regions:	the	N-terminal	pore	forming	domain	(PFD)	and	the	C-terminal	repressor	domain	(RD).	The	space	filling	models	of	the	entire	molecule	and	the	two	separate	domains	is	illustrated	in	Figure	1	below	(Liu	et	al.,	2018).	
	
	
Figure	1:	Molecular	Structure	of	GSDMD	(Liu	et	al.,	2018)	The	proposed	interaction	sites	between	the	mGSDMD-C	domain	and	the	mGSDMD-N	domain	are	illustrated	in	Appendix	B.	The	first	interaction	site,	box	I,	associates	the	α5,	α8,	and	α12	helices	on	the	c-domain	and	the	α1	helix	and	the	β1-β2	loop in	the	N-domain.	The	interaction	between	the	domains	also	could	possibly	include	the	β11-α5	loop	to	additionally	connect	the	two	domains	together.	The	second	association	site,	box	II,	involves	the	C-domain	α9	and	α11	helices	binding	to	the	N-domain	α4	helix.	It	was	also	found	that	the	surface	of	the	C-domain	is	only	negatively	charged	at	the	N-domain	interaction	sites,	where	as	the	N-domain	is	mostly	positively	charged.	This	finding	supports	the	theory	that	GSDMD-N	has	a	role	in	binding	to	the	phospholipid	bilayer	of	the	cell	membrane	(Ding	et	al.,	2016;	Liu	et	al.,	2018).		
DAMPs	and	PAMPs	Effects	on	Adaptive	Immunity	Pathogen-associated	molecular	pattern	molecules	(PAMPs)	are	specific	molecular	patterns	in	a	pathogenic	organism	that	are	recognized	by	receptors	in	the	cells	involved	in	innate	immunity.	These	receptor	regions	are	called	pattern	recognition	receptors	(PRRs)	and	can	commonly	be	found	in	macrophages,	eosinophils	and	neutrophils	in	addition	to	natural	killer	cells,	T-cells,	B-cells	and	dendritic	cells	(Tang,	Kang,	Coyne,	Zeh,	&	Lotze,	2012).	PRRs	also	serve	to	alert	the	host	immune	system	to	invading	pathogens	and	supports	adaptive	immunity.	Another	form	of	this	pattern	recognition	is	called	damage-associated	molecular	pattern	molecules	(DAMPs).	These	signal	to	neighboring	cells	that	there	has	been	an	unexpected	cell	death.	This	signal	can	result	from	damage	to	the	cell,	the	invasion	of	the	cell	by	a	microbe,	or	any	kind	of	stress	that	may	cause	cell	death.	DAMPs	and	PAMP’s	fill	the	extracellular	space	after	an	infection	or	the	untimely	death	of	a	cell	and	initiate	inflammatory	response	pathways	(Lotze	et	al.,	2007).	
Interleukin-1β	and	Interleukin-18	Members	of	the	IL-1	family,	interleukin-1β	and	interleukin-18	are	both	pro-inflammatory	cytokines	that	are	vital	for	the	successful	immune	response	of	the	host	organism.	Pro-inflammatory	cytokines	induce	an	inflammatory	immune	response	in	the	host	organism.	The	symptoms	of	this	include	but	are	not	limited	to	fever,	localized	swelling,	cell	death,	and	when	it	overwhelms	the	immune	system	it	may	cause	severe	sepsis	which	could	lead	to	the	death	of	the	host	organism	(C	A	Dinarello,	2000b).	In	controlled	levels,	the	organism	will	benefit	from	the	inflammatory	response,	but	an	excess	of	pro-inflammatory	cytokines	leads	to	hyper-inflammation,	negatively	affecting	the	host	organism.	The	inactive	precursor	of	interleukin-1β	(pro-interleukin-1β)	is	produced	by	the	host	cell	in	response	to	the	presence	of	DAMPs	and	PAMPs.	As	a	result,	the	host	cell	must	encounter	a	second	occurrence	of	a	DAMP	or	PAMP	in	order	to	activate	the	interleukin-1β	and	initiate	an	inflammatory	response	(Lopez-Castejon	&	Brough,	2011).	The	interlukin-18	precursor,	unlike	interleukin-1β	precursor,	is	always	present	even	in	healthy	cells.	This	cytokine	is	similarly	activated	by	inflammatory	response	precursors.	IL-18	is	directly	activated	by	caspase-1	and	is	secreted	by	the	cell	in	order	to	induce	an	inflammatory	immune	response	(C	A	Dinarello,	2000a;	Charles	A.	Dinarello,	Novick,	Kim,	&	Kaplanski,	2013).	
Caspase-Mediated	Inflammatory	Response	Caspases	are	a	category	of	enzymes	that	are	important	in	regulating	inflammatory	response	and	cell	death.	Caspases	exist	in	the	cell	in	their	inactive	monomeric	form	and	in	order	to	become	activated,	some	must	be	assembled	into	dimers	or	cleaved	by	precursor	caspases.	Caspase-1	is	involved	in	regulating	innate	immune	response	and	inflammation	activity	by	releasing	mature	IL-1β.	When	caspase-1	is	activated	by	the	presence	of	a	bacterium	containing	a	specific	molecular	pattern,	it	cleaves	pro-interleukine-1β	into	the	activated	form	of	IL-1β.	This	then	initiates	the	secretion	of	these	cytokines	by	the	cell	and	causes	an	inflammatory	response	in	the	surrounding	tissue	(McIlwain,	Berger,	&	Mak,	2013).	Caspase-1	is	recruited	by	canonical	inflammasome	complexes	created	in	the	cell	in	response	to	
PAMPs	or	DAMPs(Kayagaki	et	al.,	2011).	This	inflammasome	is	then	activated	by	pattern	recognition	receptors	(PRRs)	for	PAMPs	and	DAMPs.	Inflammasomes	are	comprised	of	one	or	two	types	of	nod-like	receptors	(NLRs)	at	a	time	(Guo,	Callaway,	&	Ting,	2015).	These	NLRs	are	activated	by	a	wide	variety	of	antagonists	to	the	cell,	and	upon	activation	by	the	stimulus	they	cleave	pro-caspase-1	into	the	active	form	of	caspase-1	(Fukata,	Vamadevan,	&	Abreu,	2009).	Human	caspases	-4	and	-5	have	the	homologue	caspase-11	in	the	mouse	model.	These	caspases	induce	cytotoxicity	in	the	host	cell	and	ultimately	leads	to	pyroptosis	of	the	cell.	This	type	of	inflammation	response	is	called	non-canonical	because	it	bypasses	the	canonical	inflammasome	pathway.	This	inflammatory	response	only	requires	LPS	and	pro-caspase	-4,	-5,	or	-11	to	activate	the	caspases	and	initiate	an	inflammatory	response	in	the	cell.	The	resulting	pyroptosis	floods	the	extracellular	space	with	IL-1β	and	IL-18,	therefore	initiating	an	inflammatory	response	from	the	surrounding	uninfected	cells	(Yi,	2017).	The	distinction	between	canonical	and	non-canonical	inflammasome	pathways	is	illustrated	in	Figure	2	below.		
	
Figure	2:	By	Nataliechui619	-	Own	work,	CC	BY-SA	4.0,	
https://commons.wikimedia.org/w/index.php?curid=67261834		 When	a	gram-negative	bacterium	infects	a	healthy	cell,	receptors	in	the	cytosol	of	the	cell	detect	the	cytoplasmic	lipopolysaccharide	(LPS)	embedded	in	the	outer	membrane	of	bacterium.	The	exact	mechanism	of	action	of	how	LPS	is	detected	by	caspase-11	is	unknown	(Shi	et	al.,	2014).	Once	the	LPS	is	bound	by	pro-caspase-11	in	the	cytosol,	this	complex	then	interacts	with	GSDMD.	The	Gasdermin	D	repressor	domain	is	cleaved	from	the	pore	forming	domain,	and	the	pore	forming	domain	is	allowed	to	create	a	pore	in	the	host	cell	membrane.	This	collective	process	is	illustrated	in	Figure	2	above.		
Role	of	GSDMD	in	Bacterial	Infection	When	a	macrophage	is	infected	with	a	bacterial	pathogen	according	to	the	previous	section,	caspase-1,	-4,	-5,	and	-11	cleave	Gasdermin	D	to	separate	the	molecule	into	two	domains.	Once	the	repressor	domain	is	cleaved	from	the	pore-forming	domain,	the	cytotoxic	properties	of	GSDMD	are	initiated.	The	C-terminal	repressor	domain	remains	cytosolic	while	the	N-terminal	pore	forming	domain	aggregates	in	the	cell	membrane	in	order	to	create	a	pore.	This	process	can	be	visualized	in	Figure	3	below	that	I	have	created	to	visually	simplify	the	pathway.	The	pore	becomes	a	location	where	inflammatory	caspases	escape	the	cell	and	the	proton	gradient	is	disrupted.	Water	and	extracellular	particles	enter	the	cell	and	cause	swelling	of	the	until	the	membrane	ruptures.	This	method	of	cell	death	is	called	pyroptosis	because	it	is	dependent	on	activation	by	caspase-1(Bergsbaken,	Fink,	&	Cookson,	2009).		Apoptosis	is	a	similar	cell-mediated	death	resulting	from	an	old,	infected,	or	damaged	cell,	but	does	not	produce	an	inflammatory	response.	The	cell	shrinks,	the	membrane	blebs	and	a	variety	of	caspases	initiate	this,	meaning	that	apoptosis	is	not	dependent	on	a	single	type	of	caspase	for	activation.	Cytochrome	c	leaves	the	cell	and	binds	to	apoptotic	protease	activating	factor	(apaf-1).	This	then	binds	to	pro-caspase-9	to	create	an	apoptosome.	This	then	cleaves	the	pro-caspase-9	to	make	the	active	form	of	caspase-9	which	effects	caspase-3,	thus	activating	caspase-1.	The	caspases	cascade	is	initiated	from	this	initial	caspase	activation	and	it	requires	a	variety	of	caspase-initiated	reactions	to	complete	apoptosis	of	the	entire	cell	(Bergsbaken	et	al.,	2009;	Logue	&	Martin,	2008).		
	
Figure	3:	GSDMD	Once	the	pore	in	the	membrane	is	large	enough,	extracellular	components	are	able	to	enter	the	cell	and	disrupt	the	ion	gradient	between	the	cell	and	extracellular	space.	This	is	caused	by	water	and	ions	entering	the	cell,	leading	to	cell	expansion	and	eventually	the	membrane	is	torn	from	the	pressure	and	the	cell	dies.	
In	addition	to	outside	species	entering	the	cell,	cytosolic	proteins	are	now	able	to	exit	the	cell.	Some	of	these	cytosolic	proteins	are	the	pro-inflammatory	cytokines	IL-1β	and	IL-18;	which	go	on	to	initiate	an	immune	response	in	the	host	organism	(C	A	Dinarello,	2000a;	Lopez-Castejon	&	Brough,	2011).	The	rupture	of	the	cell	membrane	also	floods	the	intracellular	space	with	the	contents	of	the	infected	cell.	The	cytokines	released	by	the	apoptotic	cell	signal	the	neighboring	cells	to	initiate	an	inflammatory	immune	response.	This	response	initiates	caspases	to	cleave	GSDMD	and	create	an	inflammatory	response	of	their	own.	Because	GSDMD	and	other	Gasdermins	are	found	in	epithelial	cells	and	mucous	membranes,	this	inflammatory	response	is	usually	localized	to	those	tissues.	The	inflammation	can	cause	skin	rashes,	gastric	pain	and	inflammation,	nausea,	and	high	fevers	(C	A	Dinarello,	2000b).		Pyroptosis	and	apoptosis	aid	organism	survival	by	recruiting	immune	response	cells	to	the	site	of	infection	or	injury.	It	may	seem	counterproductive	for	a	cell	to	create	a	strong	inflammatory	response	when	a	cell	dies	unexpectedly,	but	it	is	important	for	adaptive	immunity	in	organism	development.	Apoptosis	is	important	to	cull	the	unhealthy	cells	from	the	host	in	order	to	ensure	the	damaged	cell	does	not	affect	the	neighboring	healthy	cells.	DNA	damage,	injury,	cytotoxicity,	and	infection	are	all	reasons	for	apoptosis	and	pyroptosis	to	be	initiated	(Bergsbaken	et	al.,	2009;	Renehan,	Booth,	&	Potten,	2001).	Apoptosis	has	also	been	found	to	be	vital	for	normal	fetal	development.	Cells	that	comprise	the	nervous	system	and	the	immune	system	develop	because	of	apoptosis	from	cells	that	do	not	create	successful	neuron	connections	or	from	cells	that	fail	to	produce	antibodies.	A	healthy	adult	also	initiates	apoptosis	of	cells	to	regulate	the	number	of	viable	cells	in	the	organism	and	to	prevent	uncontrolled	and	unsustainable	growth	as	well	as	replication	of	damaged	DNA	(Renehan	et	al.,	2001).		
Salmonella	Enterica	Infection		
Salmonella	enterica	is	an	intracellular	pathogenic	bacterium	that	invades	host	cells	via	ingestion	of	contaminated	food	or	water	sources.	The	Salmonella	aggregates	in	the	intestinal	epithelium	of	the	host	organism	and	initiates	phagocytosis	in	these	cells.	Once	the	bacterium	has	entered	the	extracellular	space	surrounding	the	host	cell,	the	PRRs	and	TLRs	on	the	surface	of	the	host	cell	membrane	recognize	characteristic	parts	of	the	bacterium.	The	flagellum	on	the	
Salmonella	bacteria	is	one	of	the	recognized	patterns	(Fukata	et	al.,	2009;	Ly	&	Casanova,	2007).		In	order	to	avoid	immune	detection,	the	Salmonella	bacteria	creates	a	
Salmonella	containing	vacuole	(SCV)	so	that	it	can	avoid	direct	immune	detection	by	the	cell.	This	allows	the	bacterium	to	enter	the	cells	and	have	an	environment	suitable	for	proliferation	(“Intracellular	Infection	by	Salmonella	|	HHMI	BioInteractive,”	n.d.;	Ly	&	Casanova,	2007).	Salmonella	is	incredibly	virulent	as	a	result	of	this	pathogen’s	use	of	a	type	III	secretion	system	(T3SS).	These	secretion	systems	allow	gram-negative	pathogenic	bacteria	like	Salmonella	and	Shigella	to	bypass	the	defense	systems	in	the	cell	membrane	and	directly	inject	bacterial	effector	proteins	into	the	cytosol	of	the	host	cell	(Coburn,	Sekirov,	&	Finlay,	2007).	These	effector	proteins	change	the	environment	of	the	host	cell	to	make	the	
conditions	perfect	for	the	bacterium	adhered	to	the	surface	of	the	outer	cell	membrane	to	invade	the	cell	safely	and	proliferate	effectively.		When	the	cell	begins	producing	antimicrobial	components	such	as	cytokines	to	combat	the	change	in	homeostasis	of	the	cell,	the	Salmonella	bacteria	can	recognize	this	change	and	then	responds	by	up	regulating	the	virulence	factors	to	combat	the	host	cell	defense	mechanism.	This	allows	the	Salmonella	to	remain	in	the	SVC	and	avoid	detection	longer	(Broz,	Ohlson,	&	Monack,	2012).	In	this	experiment,	Salmonella	mutants	were	used	that	had	a	profound	effect	on	the	virulence	of	the	bacteria.	The	first	gene	mutation	of	Salmonella,	ΔHilA,	directly	affects	the	host	cell	invasion	mechanism.	HilA	is	vital	for	initiating	the	invasion	response	of	the	Salmonella	bacteria	when	in	close	proximity	to	host	cells.	This	mutation	removed	the	HilA	gene	so	that	the	bacterium	now	has	a	reduced	ability	to	invade	host	cells	(Boddicker,	Knosp,	&	Jones,	2003).	The	second	mutation	is	on	the	ΔFlhD	gene.	This	gene	is	responsible	for	the	operation	of	the	bacterial	flagella.	The	flagella	is	important	for	the	locomotion	of	the	bacteria	as	well	as	initiating	an	immune	response	from	recognition	by	NRLs	and	PRRs.	Without	this	gene,	flagella	function	is	extremely	limited	and	the	NLR	activation	also	will	decrease	substantially	(Wang	et	al.,	2016).	Both	of	these	mutations	are	expected	to	decrease	rates	of	apoptosis	in	host	cells.	
Yersinia	Pestis	Infection		 Yersinia	pestis	is	a	gram-negative	pathogenic	bacterium	that	is	found	all	across	the	globe	in	host	animals	such	as	rodents	and	fleas.	It	is	responsible	for	the	bubonic	plague,	also	known	as	the	Black	Death,	which	occurred	in	the	mid-1300s	and	killed	half	of	the	population	of	Europe.	Yersinia	pestis	is	also	classified	as	a	category	A	bioterrorism	agent.	Although	the	plague	is	popularly	thought	to	be	a	bacteria	that	does	not	effect	today’s	population,	the	World	Health	Organization	(WHO)	has	reported	that	between	the	years	of	2010	to	2015	there	were	a	total	of	3248	reported	cases	of	Yersinia	pestis.	Additionally,	the	most	recent	outbreak	in	Madagascar	reported	2348	potential	cases	between	August	and	November	of	2017	(“WHO	|	Plague	–	Madagascar,”	2017).		 Yersinia	pestis	is	similar	to	Salmonella	in	their	infection	mechanisms.	Yersinia	
pestis	invades	the	innate	immune	activity	of	the	host	organism	by	utilizing	a	T3SS	like	Salmonella.	This	secretion	system	is	made	up	of	a	variety	of	proteins,	and	the	outer	proteins	are	collectively	called	Yops.	These	proteins	are	responsible	for	the	interaction	of	the	bacteria	to	the	eukaryotic	cell	membrane	of	the	host	cells.	Other	Yops	are	integral	in	the	transport	of	the	effector	molecules	from	the	bacteria	into	the	cytoplasm	of	the	host	cell	(Bi	et	al.,	2009;	Li	&	Yang,	2008a).	YopM	is	integral	in	the	ability	of	Yersinia	pestis	to	avoid	activation	of	an	immune	response	when	the	bacteria	invades	the	cell.		YopM	directly	binds	to	caspase-1	and	renders	it	incapable	of	initiating	pyroptosis.	Because	pyroptosis	is	caspase-1	dependent,	YopM	effectively	prevents	the	death	of	the	cell	and	the	release	of	inflammatory	cytokines.	This	allows	the	
Yersinia	pestis	to	evade	detection	and	replicate	secretly	within	the	host	cell	(LaRock	&	Cookson,	2012).	The	deletion	of	the	gene	that	codes	for	this	protein	would	cause	the	presence	of	Yersinia	pestis	in	the	host	cell	to	activate	a	caspase-1	response	and	
initiate	pyroptosis.	The	pyroptosis	would	create	an	inflammatory	response	at	the	infection	site	and	the	immune	system	of	the	host	would	be	recruited	to	stop	the	spread	of	infection,	thus	lowering	the	virulence	of	the	bacteria.	In	this	lab	a	different	secretion	system	protein,	YopJ,	was	studied	in	the	infection	experiments.	YopJ	is	coded	by	the	gene	YpkA	and	is	involved	in	initiating	apoptosis	of	macrophages	(Schoberle,	Chung,	McPhee,	Bogin,	&	Bliska,	2016).	YopJ	negatively	impacts	the	production	of	inflammatory	caspases	in	the	host	cell.	YopJ	is	the	only	Yop	effector	protein	that	induces	apoptosis	in	the	host	cell	and	suppresses	tumor	necrosis	factors	(Lemaître,	Sebbane,	Long,	&	Hinnebusch,	2006).	This	means	that	Yersinia	pestis	now	has	significant	influence	over	when	the	cell	can	induce	apoptosis.	Yersinia	pestis	needs	this	ability	to	be	virulent	because	if	the	cell	induces	apoptosis	too	early	in	the	infection,	the	Yersinia	pestis	no	longer	has	a	safe	environment	to	replicate	and	will	likely	be	attacked	by	the	immune	system.	If	
Yersinia	pestis	can	prevent	the	death	of	its	host	cell,	it	can	replicate	safely	and	induce	apoptosis	when	the	mature	pathogenic	bacteria	are	ready	to	spread	to	other	cells	in	the	host	organism.	A	Yersinia	pestis	mutant	was	used	in	this	experiment	with	a	deficiency	in	Yopj.	This	mutation	is	expected	to	severely	impact	the	virulence	of	the	bacteria.	The	infected	cells	are	expected	to	induce	apoptosis	to	limit	the	spread	of	the	mature	bacteria.	
2	-	Materials	and	Methods	
2.1	Mammalian	Cell	Culture		
C57Bl/6 Cas9 BMDM (bone-marrow derived macrophages from mice)	cells	were	immortalized	by	Pontus	Orning,	a	member	of	the	lab,	using	a	J2	retrovirus 
expressing v-raf and v-myc oncogenes. These are considered the immortalized wildtype 
macrophages. Additionally, Pontus used lentivirally delivered specific gRNA to generate 
the GSDMD knock-out cells (CRISPR-Cas9 technology). The cells were then verified for 
the gene knock-out by use of GSDMD specific antibody (Genentech).	Aliquots	of	these	cells	were	collected	from	-80°F	storage.	They	were	placed	on	dry	ice,	and	when	in	the	hood	they	were	partially	thawed	then	transferred	to	a	50mL	conical	tube	containing	10mL	of	DPBS.	The	cells	were	then	placed	into	the	centrifuge	and	spun	for	5min	at	4,000rpm	in	order	to	remove	the	DMSO	before	it	caused	harm	to	the	cells.	The	supernatant	was	decanted	and	the	pellet	was	resuspended	by	gentle	pipetting	in	10mL	of	serum-free	cell	culture	media	(DMEM).	The	cell	solution	was	removed	and	transferred	to	a	75cm	cell	culture	flask.	The	cells	were	then	incubated	at	37°C	with	daily	media	changes	until	they	reached	confluency.	At	this	point	the	cells	were	split.	This	was	done	by	aspirating	the	cell	media	over	the	entirety	of	the	flask	until	no	visible	colonies	of	cells	remained	adherent	to	the	bottom.	The	media	was	collected	into	a	50mL	conical	tube	and	centrifuged.	The	pellet	was	resuspended	in	cell	media	and	only	a	fraction	was	replaced	into	the	flask.	Cell	culture	media	was	then	added	to	the	flask	to	ensure	a	thorough	covering	of	the	bottom	of	the	flask	when	it	is	laid	on	its	side.	Cell	concentration	was	determined	by	manually	counting	the	number	of	viable	cells	using	40uL	of	Tryptan	Blue	dye	and	40uL	of	the	cell	suspension.	10uL	of	this	mixture	was	pipetted	onto	a	glass	slide	and	the	viable	cells	
were	counted	using	a	microscope.	This	number	was	then	multiplied	by	2	to	account	for	the	1:2	dilution	of	the	sample	with	Tryptan	Blue	and	then	again	multiplied	by	10,000	to	account	for	the	size	of	the	microscope	slide	and	the	total	volume	of	the	solution.	The	resulting	number	is	the	amount	of	cells	per	milliliter.	
2.2	Bacterial	Cell	Culture	
Salmonella	enterica	serovar Typhimurium, strain SL1344	and	Yersinia	pestis	
strain KIM5 in	addition	to	the	mutants	discussed	about	were	cultured	fresh	before	every	experiment.	In	order	to	do	this,	the	frozen	bacterial	stocks	were	collected	from	-80°C	storage	and	placed	immediately	on	dry	ice.	The	appropriate	culture	medium	for	the	types	of	bacteria	was	determined	and	the	culture	plates	were	collected	form	the	large	walk-in	refrigerator.	A	member	of	the	lab	had	poured	them	at	a	previous	time.	 The	micro	centrifuge	tubes	containing	the	frozen	bacterium	were	scraped	with	a	cell	scraper	and	the	frozen	bacterial	solution	was	spread	evenly	on	the	appropriate	plate	for	culture.	TB	agar	was	used	for	Y.	pestis	and	LB	agar	was	used	for	Salmonella.	These	plates	were	then	put	into	either	37°C	(Salmonella)	or	26°C	(Yersinia	Pestis)	incubators	overnight.	Once	colonies	were	visible,	the	plates	were	stored	in	the	refrigerator	to	stall	their	growth	and	save	for	future	use.	On	the	day	of	the	infection	procedure,	a	pipette	tip	was	used	to	scrape	colonies	off	of	the	plates	and	into	50mL	of	the	appropriate	liquid	culture	in	a	loose-topped	vial.	The	bacterial	solutions	were	placed	into	the	appropriate	incubation	temperatures	for	their	species.	An	hour	before	the	infection,	the	Yersinia	Pestis	vials	were	moved	to	the	37°C	incubator	to	jump-start	the	infectious	state	before	adding	the	bacteria	to	the	cell	plate.		Cell	concentration	in	the	culture	media	was	determined	by	measuring	the	absorbance	of	the	bacterial	samples	in	disposable	cuvettes	using	a	small	bench	top	spectrophotometer.	The	samples	were	diluted	with	1x	PBS.	The	spectrophotometer	was	blanked	with	the	PBS	sample	without	bacteria	and	then	the	absorbance	of	the	bacterial	samples	was	measured	at	600nm.	This	was	then	used	to	calculate	how	many	colony-forming	units	(CFUs)	were	in	each	milliliter	of	the	cell	suspension.	
2.3	Bacterial	infection	The	day	before	the	bacterial	infection,	flat-bottomed	96-well	cell	culture	plates	were	plated	with	100,000	cells	per	well.	The	wells	were	planned	out	so	that	each	different	type	of	sample	was	plated	in	triplicate.	The	wells	were	filled	with	200uL	of	DMEM	cell	culture	media	without	FBS	and	the	plate	was	incubated	at	37°C	overnight.	In	the	morning,	the	media	was	aspirated	off	and	replaced	with	new	media.	The	wells	were	then	infected	with	1million	bacterial	cells/well	of	the	bacterial	strains	selected.	This	as	done	by	adding	a	small	volume	of	the	liquid	bacterial	cell	culture	to	a	volume	of	DMEM	cell	media	to	allow	for	1	million	bacterial	cells	to	be	transferred	in	200uL.	The	cell	media	was	aspirated	from	the	plate	and	200uL	of	the	bacteria	containing	media	was	added	to	each	well	in	accordance	to	the	plate	map.	The	plate	was	then	placed	in	the	designated	bacterial	infection	incubator	for	2-5	hours	at	37°C.	The	length	of	time	the	cells	incubated	for	was	determined	by	the	specific	experimental	protocol	being	followed.	Experiments	were	conducted	for	
different	time	points	to	determine	the	difference	in	total	cell	death	over	time	for	each	of	the	bacterial	strains.	After	the	bacterial	infection	was	complete	and	the	LDH	samples	were	collected,	100uL	of	supernatant	was	collected	from	each	well	and	placed	into	a	plastic	storage	96-well	plate.	This	was	covered	with	an	adhesive	plastic	cover	and	stored	in	the	freezer	until	the	ELISA	was	ready	to	be	conducted.		
2.4	Lactate	Dehydrogenase	Cytotoxicity	Assay	This	assay	was	conducted	using	the	Pierce	LDH	Cytotoxicity	Assay	Kit	from	Thermofisher	Scientific	(Part	Number:	88953).	This	assay	is	used	to	quantifiably	measure	the	level	of	cytotoxicity	in	cell	samples.	This	was	chosen	because	the	experiments	are	designed	to	compare	the	level	of	cell	death	based	on	the	bacteria	the	samples	are	infected	with.	This	assay	was	conducted	immediately	after	the	bacterial	infection	of	the	samples	was	completed.	30	minutes	before	the	end	of	the	incubation	in	chapter	2.3,	10uL	of	the	10x	Lysis	Buffer	from	the	LDH	assay	kit	was	added	to	the	triplicate	lysis	control	wells.	This	was	done	to	provide	a	sample	of	a	well	that	had	a	population	of	cells	that	were	all	theoretically	dead.	In	addition	to	this	control,	three	wells	containing	uninfected	cell	samples	were	used	as	the	non-treated	control	wells.	These	wells	theoretically	display	only	cell	death	due	to	natural	causes	instead	of	bacterial	infection.	Three	wells	were	also	plated	to	be	the	LDH	reagent	blank	wells.	These	wells	did	not	contain	cells,	and	only	contained	the	LDH	reagents	in	order	to	be	able	to	remove	their	interference	from	the	final	absorbance	readings.	Once	the	infection	was	complete	and	the	lysis	buffer	has	incubated	for	at	least	30	minutes,	50uL	of	each	sample	was	transferred	to	a	clean	96-well	flat-bottomed	plate.	It	was	ensured	at	each	sample	was	plated	in	triplicate.	This	assay	was	conducted	in	the	fume	hood	with	all	lights	turned	off	to	ensure	proper	substrate	color	development.		The	LDH	assay	kit	was	removed	from	the	freezer	and	the	Reaction	Mixture	(0.6mL	Assay	buffer	and	the	entire	volume	of	the	Substrate	Mix	reconstituted	with11.4mL	of	ultrapure	water)	was	allowed	to	thaw	in	a	place	out	of	any	direct	light.	Once	thawed,	50uL	of	Reaction	Mixture	was	added	to	each	well	and	the	plate	was	covered	with	the	lid	and	enclosed	in	aluminum	foil.	The	Lysis	control	well	contained	10uL	less	Reaction	Mixture	to	ensure	a	total	volume	of	100uL	in	each	well.	The	plate	was	allowed	to	stand	untouched	for	30	minutes	or	until	a	distinct	yellow	color	was	observed	in	the	standard	wells	and	across	the	plate.	50uL	of	the	Stop	Solution	was	then	added	to	each	well	in	order	to	inhibit	the	substrate	reaction.	Gentle	tapping	mixed	the	plate	and	all	bubbles	were	removed	from	the	surface	of	the	samples.	The	plastic	lid	was	replaced	and	the	plate	was	again	wrapped	in	aluminum	foil	to	prevent	any	further	development	of	the	substrate	color.	The	plate	was	read	in	a	microplate	spectrophotometer	at	490nm	in	order	to	determine	the	absorbance	values	of	each	of	the	wells.	The	data	was	analyzed	based	on	the	level	of	absorbance	of	the	samples	in	comparison	to	the	lysis	control	well	and	the	untreated	control	well.	The	lysis	well	was	considered	to	be	100%	cell	death,	while	as	the	untreated	well	was	considered	to	be	the	0%	cell	death.	This	untreated	well	is	intended	to	take	normal	cell	death	into	account	and	the	treated	wells	measure	the	induced	cell	death	due	to	the	bacterial	infection.	The	sample	wells	had	the	absorbance	of	the	control	well	subtracted	from	them.	
2.5	Mouse	Interlukine1-β	ELISA		The	day	before	the	ELISA	assay	was	conducted;	an	uncoated	clear-bottomed	96-well	plate	was	prepared	by	adhering	the	antibodies	to	the	bottom	of	the	plate.	The	ELISA	was	done	to	identify	the	concentration	of	interlukine1-β,	so	the	mouse	IL-1β	reagent	kit	from	Invitrogen	was	used	(Mouse	IL-1	beta	Uncoated	ELISA,	part	number:	88-7013).	The	procedure	contained	in	the	reagent	kit	was	used	to	conduct	the	assay.	The	plate	was	filled	using	a	multichannel	pipette	with	100uL/well	of	Capture	Antibody	diluted	1:250	in	1x	Coating	Buffer	(PBS	diluted	1:10	in	deionized	water).	The	plate	was	then	covered	with	a	disposable	adhesive	cover	and	incubated	at	4°C	overnight	until	the	assay	was	ready	to	be	conducted.	Following	this	incubation	period,	the	plate	was	placed	into	a	plate-washing	instrument	and	washed	three	times	with	Wash	Buffer	(1x	PBS).	The	plate	was	removed	from	the	instrument	and	tapped	upside-down	on	top	of	a	paper	towel	until	no	liquid	remained.	Each	well	was	then	filled	with	200uL	of	1x	ELISA	diluent	(Diluent	Concentrate	diluted	1:5	in	DI	water)	and	the	plate	was	left	to	incubate	at	room	temperature	for	one	hour.		During	this	incubation	period,	the	standard	reagents	were	prepared.	The	standards	need	to	be	prepared	fresh	before	every	ELISA	and	cannot	be	stored	for	later	use.	The	lyophilized	cakes	of	mouse	IL-1β	standard	were	reconstituted	with	deionized	water	to	bring	the	final	concentration	to	1000pg/mL.	Following	this	incubation,	the	plate	was	again	washed	in	the	plate	washer	and	all	excess	liquid	was	blotted	out.	Carefully	not	making	contact	with	the	bottom	of	the	wells,	a	standard	curve	of	mouse	IL-1β	concentration	was	then	prepared	on	the	now	coated	plate.	First,	100uL	of	1x	ELISA	Diluent	was	added	to	each	of	the	standard	wells,	excluding	the	first	well.	Into	the	first	standard	well,	200uL	of	the	highest	mouse	IL-1β	concentration	was	added.	From	this	well,	100uL	of	the	solution	was	pipetted	and	moved	to	the	second	well	in	the	standard	series.	For	a	total	of	8	standard	wells,	this	serial	dilution	was	conducted.	The	remaining	100uL	of	solution	at	the	end	of	the	dilution	series	was	discarded.	In	the	standard	‘blank’	well,	only	100uL	of	the	1x	ELISA	Diluent	was	added.	In	the	sample	wells,	100uL	of	each	sample	was	added	and	their	positions	were	recorded	in	a	plate	map.	Once	the	samples	were	loaded,	the	plate	was	covered	and	incubated	at	room	temperature	for	two	hours.	During	this	incubation	period,	the	Detection	Antibody	(Diluted	Detection	Antibody	1:250	in	1x	ELISA	Diluent)	was	prepared.		Once	the	incubation	was	complete,	the	plate	was	washed	in	the	plate	washer	three	times,	and	all	excess	liquid	was	blotted	on	a	paper	towel.	Once	all	excess	liquid	was	removed,	100uL	of	Detection	Antibody	was	added	to	each	well	and	the	plate	was	covered	and	incubated	at	room	temperature	for	one	hour.	During	this	incubation,	the	Avidin-HRP	solution	was	prepared	(250x	Avidin-HRP	Concentrate	diluted	1:250	in	1x	Antibody	Diluent).	Following	the	incubation,	the	plate	was	washed	three	times	in	the	plate	washer	and	excess	liquid	was	removed.	To	each	well,	100uL	of	the	HRP	enzyme	solution	was	added	and	the	plate	was	then	incubated	at	room	temperature	for	30	minutes.	The	plate	was	then	washed	and	the	excess	liquid	was	removed.	100uL	of	the	1x	TMB	Substrate	Solution	(Tetramethylbenzidine) was	added	to	each	well	and	the	plate	was	let	to	sit	undisturbed	at	room	temperature	for	15	minutes.	50uL	of	Stop	Solution	(1M	H3PO4)	
was	added	to	each	well.	The	plate	was	then	placed	into	a	microplate	spectrophotometer	and	the	absorbance	was	measured	at	450nm.	 
Chapter	3	-	Results	and	Discussion	The	mouse	macrophages	were	thawed	and	cultured	according	to	the	protocol	in	chapter	2.1.	The	cells	were	grown	in	a	37°C	incubator	with	CO2.	The	next	day,	the	cells	were	assessed	for	viability	and	confluency.	There	were	a	sufficient	number	of	cells,	so	the	experiment	moved	on	to	the	next	step.	The	cells	were	harvested	and	washed	and	then	plated	in	a	96-well	plate.	The	plate	was	then	placed	in	the	same	incubator	for	another	night.	The	bacterial	cultures	were	thawed	and	plated	on	the	same	day	the	cells	were	plated	into	the	96-well	plate.	The	liquid	culture	bacteria	strains	were	placed	in	the	appropriate	incubators	overnight,	which	are	illustrated	in	chapter	2.2.	On	the	morning	of	the	infection,	the	bacteria	in	the	liquid	culture	was	diluted	1:10	in	culture	media	and	allowed	to	incubate	for	an	hour.	After	the	hour,	the	Yersinia	pestis	strains	were	transferred	to	the	37°C	incubator	to	amplify	their	virulence.	The	bacterial	cultures	were	left	for	another	two	hours	and	then	were	analyzed.	The	absorbance	data	is	shown	in	Table	2	below.		
Table	2:	Absorbance	values	of	Bacterial	Cultures	
OD600 Absorbance 
Kim5 1.636 
Yop J 1.892 
SL1334 1.839 
HilA 0.841 
FlhD 3.366 	 The	absorbance	values	were	then	multiplied	by	the	multiplicity	of	infection	(MOI)	of	each	type	of	bacteria.	Yersinia	pestis	strains	were	multiplied	by	4.4x108	and	the	Salmonella	samples	were	multiplied	by	7.6	x108	in	order	to	determine	the	colony	forming	units	in	one	milliliter	(CFU/mL)	of	each	bacterial	culture.	The	results	of	the	calculation	are	shown	in	Table	3	below.	Additionally,	the	volume	of	the	stock	bacterial	cell	culture	to	add	to	5mL	of	DMEM	mammalian	cell	culture	media	was	calculated	in	microliters.	This	calculation	was	used	to	add	the	appropriate	amount	of	bacterium	to	each	well	in	the	cell	culture	plate.							
Table	3:	Bacterial	Concentration	Calculations	
Bacteria 
CFU/mL in 
Eppendorf 
CFU in 
5mL 
V(mL) to add to 5mL of 
DMEM 
uL to add to 5mL of 
DMEM 
Kim5 719840000 10000000 0.0694599 69.46 
Yop J 832480000 10000000 0.0600615 60.06 
SL1334 1397640000 2000000 0.0357746 35.77 
HilA 639160000 2000000 0.0782277 78.23 
FlhD 2558160000 2000000 0.0195453 19.55 	 	The	cell	plate	was	aspirated	of	cell	media	and	the	bacteria-containing	cell	media	was	added	to	the	appropriate	wells.	Uninfected	DMEM	was	added	to	control	and	lysis	wells.	The	cells	were	covered	and	incubated	at	37°C	for	two	hours.	At	this	point,	10mg/mL	of	gentamycin	was	added	to	each	of	the	bacteria	containing	wells	to	limit	the	growth	of	the	bacterial	cells.	The	plate	was	then	incubated	for	and	additional	4	hours	to	ensure	maximum	infection	rates.	30min	before	the	harvest,	lysis	buffer	was	added	to	the	lysis	wells	to	serve	as	a	control	for	the	LDH	assay.			 This	experiment	resulted	in	an	LDH	plate	that	had	no	signal.	The	cause	of	the	blank	plate	was	not	discovered,	but	the	experiment	was	repeated.	All	new	cells	were	cultured	and	new	cell	media	was	used	to	eliminate	possible	sources	of	contamination.	After	repeating	the	infection,	another	LDH	assay	was	performed	following	the	procedure	in	chapter	2.4,	and	the	results	were	collected	into	Table	4	below.	
Table	4:	LDH	Assay	Absorbance	Data	
 
Wild Type GSDMD 
Blank 0.1538 0.1587 0.1449 0.1722 0.1671 0.1834 
Lysis 0.5249 0.5565 0.6534 0.6779 0.7106 0.764 
Kim5 0.2336 0.2885 0.2516 0.2883 0.2414 0.2894 
ΔYop J 0.2271 0.2278 0.2032 0.1725 0.1616 0.1719 
SL1334 0.4572 0.573 0.5125 0.5643 0.4231 0.6232 
SLΔFlhD 0.2182 0.2614 0.2392 0.2158 0.2125 0.1957 
SLΔHilA 0.1799 0.2761 0.2405 0.2308 0.2832 0.2206 		 The	raw	data	as	then	calculated	to	be	representative	of	a	percentage	cell	death	of	the	total	cells	in	the	well.	This	was	done	by	subtracting	the	average	of	the	absorbance	values	of	the	blank	wells	from	every	other	absorbance	value	in	the	table.	The	corrected	absorbances	were	then	divided	by	the	average	of	the	lysis	control	wells	to	determine	the	ratio	of	LDH	found	in	the	sample	wells	to	the	LDH	concentration	found	in	the	lysis	control	wells.	The	lysis	control	was	considered	to	be	complete	cell	death	and	maximum	LDH	concentration.	This	is	shown	in	Figure	5	below.	
Table	5:	LDH	of	Wildtype	Macrophages	vs	LDH	of	GSDMD	knockout	Macrophages	
				 After	the	LDH	assay	was	completed	and	the	results	were	calculated,	it	was	determined	that	the	Kim5	sample,	wildtype	Yersinia	pestis,	did	not	have	the	LDH	levels	that	were	expected.	The	levels	appear	to	be	significantly	lower	than	that	of	the	
Salmonella	sample.	It	is	undetermined	if	the	source	of	contamination	was	completely	eliminated	in	this	repeat	experiment,	but	it	was	decided	that	the	plate	could	be	used	to	conduct	and	ELISA	assay	because	there	may	still	be	IL-1β	present	in	the	supernatant.	The	samples	were	collected	and	frozen	overnight.	The	next	day,	the	samples	were	thawed	and	the	ELISA	protocol	was	followed	that	is	illustrated	in	chapter	2.5	to	look	for	mouse	IL-1β	present	in	the	samples.	The	standard	curve	was	calculated	from	the	absorbance	of	the	standard	samples	added	to	the	plate.	This	can	be	seen	in	Figure	4	below.		
	
Figure	4:	ELISA	Standard	Curve	of	Mouse	IL-1	beta	
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After	the	standard	curve	was	created,	the	IL-1	beta	concentration	of	each	of	the	samples	could	be	calculated.	This	can	be	seen	in	Table	6	below.		
Table	6:	IL-1	beta	Concentration	Calculations	
 
CONCENTRATION (ng/mL) 
     
Control/ NT 
 
-0.062632 0.190664 
 
0.317312 -0.125956 
Kim5 0.887228 0.718364 0.697256 0.570608 0.528392 0.275096 
Yop J 1.858196 1.647116 1.224956 1.0772 0.718364 0.97166 
SL1334 5.79132 7.19852 2.8362 5.15808 2.62512 2.69548 
FlhD 5.50988 3.82124 3.11764 3.32872 1.99188 2.4844 
HilA 4.17304 3.188 2.41404 2.20296 1.71044 1.49936 	These	concentrations	in	nanograms	per	milliliter	were	graphed	to	visually	see	the	concentrations	of	IL-1	beta	across	all	of	the	different	samples.	This	can	be	seen	in	Figure	5	below.		
	
Figure	5:	Mouse	IL-1	beta	Concentrations			 Due	to	the	results	of	the	ELISA	correlating	with	the	LDH	results,	it	was	determined	that	the	Kim5	bacteria	samples	were	either	contaminated	or	some	external	factor	limited	the	virulence	of	the	bacteria.	The	other	bacterial	mutations	performed	as	expected.	The	mutations	all	caused	a	drop	in	the	total	cell	death	of	the	infected	macrophages.	This	confirms	that	these	specific	mutations	are	integral	to	cell	death	regulation	in	the	bacterium.	This	experiment	was	repeated	again	to	determine	better	results,	but	the	experiment	collected	incredibly	poor	data.	There	was	some	troubleshooting	conducted	again,	but	the	problems	were	not	resolved.	A	future	MQP	may	wish	to	investigate	why	these	infections	did	not	produce	the	expected	results.	 	
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Appendix	A:	Chromosome	Locations	of	Gasdermin	Family	Members	(Tamura	et	
al.,	2007)	
	
				 	
Appendix	B:	GSDMD	Molecular	Structure	and	Domain	Interaction	Sites	The	complete	molecular	structures	of	GSDMD	are	modeled	below.	The	sites	where	GSDMD-C	and	GSDMD-N	interact	are	shown	in	the	I	and	II	labeled	boxes	(Liu	et	al.,	2018).	
	
	
Appendix	C:	Yersinia	Pestis	Infection	via	Flea	Bite	Diagram	of	Yersinia	pestis	infection	of	host	organism	cell	types	(Li	&	Yang,	2008b).	
	
